All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F12%3A10124512" target="_blank" >RIV/00216208:11160/12:10124512 - isvavai.cz</a>

  • Result on the web

    <a href="http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2012.03973.x/full" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/j.1469-0691.2012.03973.x/full</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/j.1469-0691.2012.03973.x" target="_blank" >10.1111/j.1469-0691.2012.03973.x</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009

  • Original language description

    The study aimed to identify targets for quality improvement in antifungal use in European hospitals and determine the variability of such prescribing. Hospitals that participated in the European Surveillance of Antimicrobial Consumption Point PrevalenceSurveys (ESAC-PPS) were included. The WHO Anatomical Therapeutic Chemical (ATC) classification for antimycotics for systemic use (J02) 2009 version was used. Demographic data and information about indications and diagnoses were collected in 2008 and 2009. From 99 053 patients, 29 324 (29.6%) received antimicrobials. Antifungals represented 1529 of 40 878 (3.7%) antimicrobials. Antifungals were mainly (54.2%) administered orally. Hospital-acquired infections represented 44.5% of indications for antifungals followed by medical prophylaxis at 31.2%. The site of infection was not defined in 36.0% of cases but the most commonly targeted sites were respiratory (19.2%) and gastrointestinal (18.8%). The most used antifungal was fluconazole (60.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2012

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Clinical Microbiology and Infection

  • ISSN

    1198-743X

  • e-ISSN

  • Volume of the periodical

    18

  • Issue of the periodical within the volume

    10

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    7

  • Pages from-to

    "E389"-"E395"

  • UT code for WoS article

    000308579400003

  • EID of the result in the Scopus database